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Hodgkin’s lymphoma may involve the lymph nodes, the thymus or both. It is the most
frequent lymphoid proliferation in the mediastinum. Symptoms and radiological findings
are non-specific. These tumors must be considered in case of thymus involvement in order
to avoid a surgical treatment which could lead to many complications. We report a case of
primary Hodgkin’s lymphoma of thymic origin in a 39-year-old woman, with a past medical
history of a pleomorphic adenoma of the parotid, who presented with a chest pain. Simple
chest radiography showed an anterosuperior mediastinal mass. Thoracic computed
tomography revealed an 8-cm and heterogeneous thymic tumor with an involvement of
mediastinal nodes. The suggested diagnosis was thymoma. A thymectomy with resection of
the involved nodes was undergone via a left posterolateral thoracotomy. The definitive
histologic study revealed a Hodgkin’s lymphoma classified as a nodular sclerosing type,
which was confirmed by the immunohistochemistry. This case was stage I according to the
Costwold classification. The patient received treatment based on 5 cycles of chemother-
apy in association to radiotherapy. The response was total with a complete remission
without recurrences after a follow up of 2 years. Thymic Hodgkin’s lymphoma must always
be considered among the diagnostic options, because the prognosis is strongly dependent
on correct early treatment. Treatment is based on radiotherapy and chemotherapy. The
main prognostic factors are the size of the tumors, direct invasion of the lung or adjacent
tissues, advanced stage, presence of constitutional symptoms and age older than 50–60
years.
& 2007 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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8862.
@hotmail.com (M. Mlika).The mediastinum is the common site for the occurrence of
malignant lymphoma. Undoubtedly, most mediastinal malig-
nant lymphomas originate in one or more of the many lymph
nodes normally present in this location. The fact that the
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Figure 2 Showing a thymic architecture in some areas.
Figure 3 Showing inflammatory granuloma containing Hodgkin
and Reed–Sternberg cells.
Thymic Hodgkin lymphoma 49thymus is a lymphoid organ makes it a site for lymphomatous
tumor, although primary lymphomas of the thymus are
uncommon.1 Hodgkin’s disease may involve the lymph
nodes, the thymus or both. It is the most frequent lymphoid
proliferation in the mediastinum. Thymic Hodgkin’s lympho-
ma must always be considered among the diagnostic
options, because the prognosis is strongly dependent on
correct early treatment.2
We report a case of primary Hodgkin’s lymphoma of
thymic origin in a 39-year-old woman, with a past medical
history of a pleomorphic adenoma of the parotid, who
presented with a chest pain. The time between the onset of
symptoms and consultation was 1 month. Clinical examina-
tion was normal. Simple chest radiography showed an
anterosuperior mediastinal mass. Thoracic computed tomo-
graphy revealed an 8-cm and heterogeneous thymic tumor
with an involvement of mediastinal nodes. The suggested
diagnosis was thymoma. A thymectomy with resection of the
involved nodes was undergone via a left posterolateral
thoracotomy. Macroscopic findings consisted in multiple firm
grayish-white nodules with visible fibrous bands (Figure 1).
Histopathologic examination showed a nodular infiltrate of
the thymus that comprises variable numbers of Hodgkin and
Reed–Sternberg cells (Figures 2 and 3). The definitive
histologic study revealed a Hodgkin disease classified as a
nodular sclerosing type, which was confirmed by the
immunohistochemistry. This case was stage I according to
the Costwold classification. The patient received treatment
based on five cycles of chemotherapy (ABVD; Adriamycin,
Ble´omycine, Vinblastine and Dacarbazine) and radiotherapy.
The response was total with a complete remission without
recurrences after a follow up of 2 years.
Thymic Hodgkin’s lymphoma was considered in the past as
a peculiar morphologic variant of thymoma. The alternative
view that this disease represents Hodgkin’s disease involving
the thymus was clearly expressed by Castelman in 1955.3
Hodgkin’s lymphoma of thymic origin manifests itself in the
second to third decades of life and more frequently in men
in opposition to the systemic Hodgkin’s disease which
appears at the second and third decades and after the fifth
decade of life and is more common in women.4 It is
especially predominant in industrialized countries, in highFigure 1 Showing a lobulated, firm, yellow-tan cut surface of
the thymic tumor.socioeconomic groups and urban areas. History of infectious
mononucleosis increases the incidence of Hodgkin’s disease.
Both, familial and geographical clusterings have been
described.5 Patients are generally asymptomatic until
extrathymic disease develops, which is generally when the
diagnosis is made. The presence of adenopathies is
common.6 On diagnosis, a third of the patients usually have
fever, nocturnal sweating, and weight loss.1 A case of thymic
Hodgkin’s disease presented as an inflammatory tumor was
reported by Campanelli et al.7 Coughing, dyspnea or chest
pain, like in our case, are related to the compression or the
invasion of mediastinal structures. An association of thymic
Hodgkin’s lymphoma and myasthenia was also reported by
Null JA et al.5 Nearly 100% of the patients have radiological
evidence of intrathoracic disease in the form of an anterior
mediastinal mass as was true in our patient. CT scan shows
generally a solid heterogeneous thymic mass, with the
presence of additional thoracic adenopathies helping to
suggest the diagnosis.1,2 In many cases, a thymic enlarge-
ment is reported.8 CT scan is very useful for assessing the
invasion of adjacent structures, although MRI has been used
in recent years since the images can better distinguish the
thymic tumor from neighboring structures.2 Differential
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A. Ayadi-Kaddour et al.50diagnosis includes thymoma, large cell lymphoma of the
mediastinum, anaplasic large cell lymphoma and mediast-
inal fibrosis. Fine needle aspiration has been used for the
differential diagnosis of thymic lesions, especially when
tymomas are suspected.9 Despite all the diagnostic techni-
ques, it is difficult to obtain definitive preoperative
diagnosis in most thymic lesions. In our case, the diagnosis
of thymoma was retained in relation to the radiological
findings. Therefore, surgeons must often resort to an open
biopsy. The approach of choice is an anterior mediastinot-
omy. Some authors have performed resection of the thymus
in Hodgkin’s disease and most accepted that biopsy is
enough to confirm the lymphoma and its variant, because
treatment is based on radiotherapy and chemotherapy,
besides some authors reported postoperative complications
after removal of the thymus.2 In our case, a removal of the
thymus was performed and no complications were reported
postoperatively. Macroscopically, the thymus involved by
Hodgkin’s lymphoma show multiple firm white nodules with
or without visible fibrous bands. On histological study, the
most common type is nodular sclerosis, as the other types
typically affect lymph nodes except the thymus.6 Hodgkin’s
lymphoma is characterized by a microscopic nodularity,
composed of lymphoid cells interspersed with a marked
inflammatory cell reaction and separated by wide fibrous
band. Identification of lacunar variant of Reed–Sternberg
cells confirms the diagnosis. Involvement of the thymus by
Hodgkin lymphoma often results in cystic changes, and
pseudoepithelial hyperplasia of thymic epithelium mimick-
ing thymoma on small biopsies. Immunohistochemistry is
important to confirm the diagnosis. There is no difference
with systemic HL. Tumour cells strongly and consistently
express CD30. CD15 is detectable in more than 85% of the
cases. Hodgkin’s lymphoma associated with EBV express LMP
in 30% of the cases. Anatomic staging is a good predictor of
survival. Classically, the Ann Arbor system has been used.
This has now been updated (Cotswold Ann Arbor modified
staging system).1 Treatment of Hodgkin disease is based on
radiotherapy and chemotherapy. Modalities of treatment
depend on the Cotswold staging system. In stage I or II,
radiotherapy is adequate. In patients with stage III or IV,
treatment is chemotherapy occasionally combined with
radiotherapy.10 Hodgkin’s disease evolving the thymus gland
predisposes to cystic degeneration especially following
radiotherapy.11 Sometimes a residual mass remains after
treatment, and determining whether it is fibrosis or a viable
tumor is difficult especially in the first few months.1,5
Positron emission tomography and gammagraphy with
gallium 67 currently seem to be the most useful for
determining whether this residual area harbors tumor
activity or merely fibrosis. Survival rates depend on thetumor staging. It accounts for 90% in stages I and II tumors,
65% to 85% in stage III tumors and 50% to 60% in stage IV
tumors.4,6,10 Approximately 50% of the patients have
recurrence of the disease. It is necessary to wait two
decades to consider a patient totally cured with practically
no possibility of recurrence.2 The follow up of our patient
was only of 2 years, so we cannot regard her as cured.
Hodgkin’s disease is the most common type of thymic
lymphoma. Symptoms and radiological findings are non-
specific. These tumors must be considered in case of thymus
involvement in order to avoid a surgical treatment which
could leads to many complications. Treatment is based on
radiotherapy and chemotherapy. The main prognostic
factors are the size of the tumors, direct invasion of the
lung or adjacent tissues, advanced stage, presence of
constitutional symptoms and age older than 50–60 years.Conflict of interest statement
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